Literature DB >> 8104816

A molecular characterization of Clostridium difficile isolates from humans, animals and their environments.

G O'Neill1, J E Adams, R A Bowman, T V Riley.   

Abstract

It is generally accepted that most patients with Clostridium difficile-associated diarrhoea acquire the organism from the environment. Recently we demonstrated that household pets may constitute a significant reservoir of C. difficile through gastrointestinal carriage in up to 39% of cats and dogs. These findings suggested that direct transmission from household pets, or contamination of the environment by them, may be a factor in the pathogenesis of C. difficile-associated diarrhoea. To investigate this possibility, we examined isolates of C. difficile from humans, pets and the environment by restriction enzyme analysis (REA) and restriction fragment length polymorphism (RFLP) typing using enhanced chemiluminescence. Both REA and RFLP typing methods used Hind III digests of chromosomal DNA. A total of 116 isolates of C. difficile from pets (26), veterinary clinic environmental sites (33), humans (37) and hospital environmental sites (20) was examined. REA was far more discriminatory than RFLP typing and for all isolates there were 34 REA types versus 6 RFLP types. There was good correlation between the REA types found in isolates from pets and from the veterinary clinic environment, and between isolates from humans and from those found in the hospital environment. There was, however, no correlation between REA type of C. difficile found in pets and isolates of human origin. We conclude that there may still be a risk of humans acquiring C. difficile from domestic pets as these findings may be the result of geographical variation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104816      PMCID: PMC2271396          DOI: 10.1017/s095026880005696x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Restriction endonuclease DNA analysis of Clostridium difficile.

Authors:  B W Wren; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

2.  Non-radioactive restriction fragment length polymorphism (RFLP) typing of Clostridium difficile.

Authors:  R A Bowman; G L O'Neill; T V Riley
Journal:  FEMS Microbiol Lett       Date:  1991-04-15       Impact factor: 2.742

3.  Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea.

Authors:  E J Kuijper; J H Oudbier; W N Stuifbergen; A Jansz; H C Zanen
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

4.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

5.  Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.

Authors:  D Seal; S P Borriello; F Barclay; A Welch; M Piper; M Bonnycastle
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

6.  Clostridium difficile plasmid isolation as an epidemiologic tool.

Authors:  C Clabots; S Lee; D Gerding; M Mulligan; R Kwok; D Schaberg; R Fekety; L Peterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

7.  Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions.

Authors:  A Pantosti; M Cerquetti; P M Gianfrilli
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

8.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients.

Authors:  L V McFarland; C M Surawicz; W E Stamm
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

9.  Immunoblot analysis of serum immunoglobulin G response to surface proteins of Clostridium difficile in patients with antibiotic-associated diarrhea.

Authors:  A Pantosti; M Cerquetti; F Viti; G Ortisi; P Mastrantonio
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

View more
  11 in total

1.  Pulsed-field gel electrophoresis of degradation-sensitive DNAs from Clostridium difficile PCR ribotype 1 strains.

Authors:  J E Corkill; R Graham; C A Hart; S Stubbs
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Clostridium difficile: a pathogen of the nineties.

Authors:  T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

Review 3.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 4.  Clostridium difficile Infection in Children: Current State and Unanswered Questions.

Authors:  Pranita D Tamma; Thomas J Sandora
Journal:  J Pediatric Infect Dis Soc       Date:  2012-07-25       Impact factor: 3.164

5.  Microarray identification of Clostridium difficile core components and divergent regions associated with host origin.

Authors:  Tavan Janvilisri; Joy Scaria; Angela D Thompson; Ainsley Nicholson; Brandi M Limbago; Luis G Arroyo; J Glenn Songer; Yrjö T Gröhn; Yung-Fu Chang
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

6.  Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types.

Authors:  Ludovic Lemee; Anne Dhalluin; Martine Pestel-Caron; Jean-François Lemeland; Jean-Louis Pons
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

7.  Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species.

Authors:  Kevin Keel; Jon S Brazier; Karen W Post; Scott Weese; J Glenn Songer
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

8.  Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants.

Authors:  Lisa F Dawson; Esmeralda Valiente; Elizabeth H Donahue; George Birchenough; Brendan W Wren
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

9.  Toxinotype V Clostridium difficile in humans and food animals.

Authors:  Michael A Jhung; Angela D Thompson; George E Killgore; Walter E Zukowski; Glenn Songer; Michael Warny; Stuart Johnson; Dale N Gerding; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

10.  CD2068 potentially mediates multidrug efflux in Clostridium difficile.

Authors:  Chawalit Ngernsombat; Suthasinee Sreesai; Phurt Harnvoravongchai; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.